Inpatient Adolescent Contraception

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

December 10, 2020

Primary Completion Date

April 1, 2022

Study Completion Date

April 4, 2023

Conditions
Pregnancy RelatedContraceptionContraceptive UsageContraception BehaviorPregnancy
Interventions
BEHAVIORAL

SexHealth II

SexHealth II is an intervention that will focus exclusively on provision of hormonal contraception counseling and provision for hospitalized female adolescents

DRUG

Contraceptive

"The investigators will offer initiation of the following contraceptives:~Ethinyl Estradiol and Etonogestrel 0.015mg-0.12mg vaginal ring (Nuva Ring) Etonogestrel 68mg subcutaneous implant (Nexplanon) Medroxyprogesterone 150mg/ml 150 mg IM injection Ethinyl Estradiol and Norgestimate (Sprintec) 35mcg-0.25mg tablet Norelgestromin/Ethinyl estradiol transdermal patch (Ortho Evra) Norethindrone 0.35mg tablet~Emergency Contraception:~Ulipristal 30 mg tablet Levonorgestrel 1.5mg tablet"

Trial Locations (1)

64108

Children's Mercy Hospitals and Clinics, Kansas City

All Listed Sponsors
lead

Children's Mercy Hospital Kansas City

OTHER

NCT04423068 - Inpatient Adolescent Contraception | Biotech Hunter | Biotech Hunter